Patent · US Active

Formulations of histone deacetylase inhibitor and uses thereof

US8603521B2 · kind B2 · utility

8Cited by

22References

13Claims

0Family size

Assignee

Pharmacyclics LLC · US

Inventors

David J. Loury · San Jose, US
Joseph J. Buggy · Mountain View, US
Tarak D. Mody · Sunnyvale, US
Erik Verner · San Diego, US
Norbert Purro · Los Gatos, US
Sriram Balasubramanian · Singapore, SG

Key dates

Filing date	Apr 16, 2010
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Jan 13, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D307/85
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.